Atorvastatin
Back to searchMolecule Structure
Scientific Name
Atorvastatin
Description of the Drug
Atorvastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01076
http://www.drugbank.ca/drugs/DB01076
Brand Name(s)
Cardyl, Lipitor, Prevencor, Sortis, Tahor, Zarator
Company Owner(s)
Alkem Laboratories Ltd, Upjohn Manufacturing Ireland Unltd, Invagen Pharmaceuticals Inc, August Pharmaceuticals Llc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Graviti Pharmaceuticals Private Ltd, Perrigo R And D Co, Accord Healthcare Inc, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| HMG-CoA reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL402 |
Clinical Trial(s)
Unichem Links
| Atlas | atorvastatin | |||
| SureChEMBL | SCHEMBL3831 | |||
| PharmGKB | PA448500 | |||
| Human Metabolome Database | HMDB0005006 | |||
| DrugBank | DB01076 | |||
| PubChem: Thomson Pharma | 14910832 | |||
| PubChem | 60823 | |||
| Mcule | MCULE-2368532812 | |||
| LINCS | LSM-5771 | |||
| Nikkaji | J596.930A | |||
| PDBe | 117 | |||
| BindingDB | 22164 | |||
| EPA CompTox Dashboard | DTXSID8029868 | DTXSID60274003 | ||
| DrugCentral | 257 | |||
| Brenda | 4365 | |||
| ChemicalBook | CB4239912 | CB81269853 | ||
| Guide to Pharmacology | 2949 | |||
| rxnorm | ATORVASTATIN CALCIUM TRIHYDRATE | ATORVASTATIN | LIPITOR | ATORVASTATIN CALCIUM |
| KEGG Ligand | C06834 | |||
| ChEBI | 39548 | |||
| ZINC | ZINC000003920719 |
